Metraipolis › archive › dc_cd23c013847d

Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience — Europe PMC PMID:42453165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42453165
DOI
10.3332/ecancer.2026.2150
License (as archived)
solo-consultazione
Archived
2026-10-28T03:03:06.097Z
SHA-256 of the archived text
2f821b4cc56fbc8bbf39d891da1aa490103a9bf6ce162b6c100882dbf9f04384
Stable URL of this page
https://metraipolis.com/documento/dc_cd23c013847d

How to cite

Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience — Europe PMC PMID:42453165 — Europe PMC (en), https://europepmc.org/article/MED/42453165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd23c013847d (Metraipolis archive dc_cd23c013847d, sha256 2f821b4cc56fbc8bbf39d891da1aa490103a9bf6ce162b6c100882dbf9f04384)
BibTeX
@misc{dccd23c013847d,
  title = {Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience — Europe PMC PMID:42453165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42453165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd23c013847d; sha256 2f821b4cc56fbc8bbf39d891da1aa490103a9bf6ce162b6c100882dbf9f04384},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42453165. Agents can read the archived copy with the MCP tool read_document.